Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05288582 · ClinicalTrials.gov registry record · NA
Tear Lipid Layer Thickness Assessments With Perfluorohexyloctane Eye Drops
A NA study of Dry Eye, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05288582: Completed NA study of Dry Eye, sponsored by Ohio State University.
NCT05288582 is a NA study of Dry Eye that has completed, run by Ohio State University. The registered enrollment target is 20 participants, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05288582, a NA study of Dry Eye, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to explore the tear lipid layer quantitatively and qualitatively before and after use of a perflurohexyloctane eye drop (NovaTears)
Conditions Studied
Interventions
- DEVICE NovaTears
Study Locations (1)
Ohio
- The Ohio State University College of Optometry - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-03-27 |
| Est. Completion | 2022-11-30 |
| Phase | NA |
What the finished NCT05288582 record still lists
NCT05288582 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Dry Eye appearing as the primary indexed condition, and to 1 intervention - of which NovaTears is the first listed.
NCT05288582 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05288582 about?
NCT05288582 is a clinical study titled "Tear Lipid Layer Thickness Assessments With Perfluorohexyloctane Eye Drops". The purpose of this study is to explore the tear lipid layer quantitatively and qualitatively before and after use of a perflurohexyloctane eye drop (NovaTears)
What is the current status of trial NCT05288582?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-03-27. Estimated completion is 2022-11-30.
What conditions does trial NCT05288582 study?
This clinical trial studies the following conditions: Dry Eye.
What interventions are being tested in trial NCT05288582?
The interventions under investigation include: NovaTears (DEVICE).
Who is sponsoring clinical trial NCT05288582?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05288582 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05288582's enrollment target sits among peer trials
20 35th of 41 higher than 4 of 41 other Dry Eye trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dry Eye trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The THINK Study Incidence of Neurotrophic Keratopathy)
RECRUITING · NA
-
Low Level Light Therapy & Skin Pigmentation
RECRUITING · NA
-
Corneal Epithelial Stem Cells and Dry Eye Disease
COMPLETED · NA
-
Acute Comfort of Lubricant Eye Drops FID 112903
COMPLETED · NA
-
Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion
COMPLETED · NA
-
Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI